Armata Pharmaceuticals Inc (ARMP)
Who owns Armata Pharmaceuticals Inc (ARMP)? This page shows the largest institutions and funds, the ownership structure and the latest insider transactions. 31.5% of the shares are freely tradable; institutional investors hold 10.5%.
Ownership Structure
No ownership data is available for this stock yet.
Insider Transactions
| Date | Person | Role | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 10. Jul 2026 | Birx Deborah | Chief Executive Officer | Other | 14,041 | 4.26 | 59,815 |
Reportable transactions by officers and major shareholders from SEC Form 4 filings. "Other" includes things like stock grants and option exercises without a buy/sell character.
View all insider transactions →Data as of: July 31, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.